Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc.
ARMP
Valuace
100
Růst
46
Zdraví
75
Cena
$ 6.35
Dnes
+0.02 (0.31%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
49%
ROA
-52%
PE
-2
PS
62
Cena 1R
1-16
⌀ Cena
3.44
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
19-03-2026
Poslední dividenda

Profil

Armata Pharmaceuticals, Inc., biotechnologická společnost v klinickém stadiu, se zaměřuje na vývoj cílené bakteriofágové terapie pro antibiotické infekce po celém světě. Vyvíjí své produkty s využitím vlastní technologie založené na bakteriofágu. Mezi produkty, které společnost nabízí, patří AP-SA02 pro léčbu bakteremie Staphylococcus aureus, AP-PA02 pro Pseudomonas aeruginosa a AP-PA03 pro léčbu pneumonie. Má partnerskou smlouvu se společností Merck & Co. na vývoj kandidátů syntetického bakteriofágu zaměřených na nezveřejněné původce infekčních nemocí. Společnost sídlí v Marina del Rey v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
60
Založení
1994-05-20
Adresa
4503 Glencoe Avenue
CEO
Deborah L. Birx

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 20252024202320222021202020192018201720162015201420132012
Total Revenues4.94.95.24.50.00.00.00.00.00.10.30.50.40.30.7
Cost of Revenues1.51.534.433.80.00.00.00.00.00.00.00.00.00.00.0
Gross Profit3.43.4-29.3-29.20.00.00.00.00.00.10.30.50.40.30.7
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues1.11.22.20.51.23.00.01.01.51.2
Cost of Revenues0.40.40.40.40.40.30.30.30.30.2
Gross Profit0.70.81.80.10.92.7-0.30.61.21.0
Operating Income TTM 20252024202320222021202020192018201720162015201420132012
R&D Expenses0.00.00.033.835.020.014.49.84.92.95.74.05.86.51.5
Selling General & Admin Expenses0.00.00.011.67.48.38.09.35.77.68.46.78.78.83.2
Depreciation & Amortization1.51.51.31.00.91.21.11.60.40.40.40.30.20.10.1
Total Operating Expenses34.634.613.211.636.923.821.619.110.610.514.110.714.515.34.7
Operating Income-31.2-31.2-42.4-40.9-36.9-23.8-21.6-19.8-12.5-16.2-23.4-10.2-14.1-15.0-4.0
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.07.98.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.02.93.6
Depreciation & Amortization0.40.40.40.40.40.30.30.30.30.2
Total Operating Expenses9.18.68.68.311.412.411.610.910.810.3
Operating Income-8.4-7.8-6.8-8.2-10.5-9.8-11.9-10.2-9.6-10.3
Net Income TTM 20252024202320222021202020192018201720162015201420132012
Interest Income0.40.40.70.20.00.00.00.10.00.00.00.00.00.00.0
Interest Expense16.616.610.72.60.00.10.60.90.00.00.00.00.02.90.3
Other Expense-142.6-142.623.5-28.20.00.7-0.60.3-1.8-3.8-5.69.637.2-40.60.1
IBT-173.8-173.8-18.9-69.0-36.9-23.2-22.2-19.5-12.4-14.1-19.4-0.623.1-58.4-4.3
Income Tax Expense0.00.00.00.00.00.10.6-0.5-0.3-1.3-0.6-0.1-37.243.4-3.2
Net Income-173.8-173.8-18.9-69.0-36.9-23.2-22.8-19.0-12.1-12.8-18.8-0.523.1-58.4-1.1
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.10.10.10.10.10.30.20.10.10.0
Interest Expense4.84.33.83.63.32.92.71.81.51.2
Other Expense-115.9-18.9-9.51.713.14.320.9-14.8-10.3-20.8
IBT-124.3-26.7-16.3-6.52.6-5.59.0-25.0-19.8-31.2
Income Tax Expense0.00.00.00.00.00.00.00.017.8-14.7
Net Income-124.3-26.7-16.3-6.52.6-5.59.0-25.0-19.8-31.2
Per Share Data TTM 20252024202320222021202020192018201720162015201420132012
EPS$0.00$0.00$0.00$-1.91$-1.08$-0.96$-1.39$-2.84$-8.93$-28.14$-268.06$-13.35$589.40$-4,040.33$-161.76
EPS Diluted$0.00$0.00$0.00$-1.91$-1.08$-0.96$-1.39$-2.38$-8.90$-27.34$-268.06$-13.35$-326.20$-4,040.33$-161.76
Shares Outstanding36.236.236.236.134.324.116.46.71.40.50.10.00.00.00.0
Diluted Shares Outstanding36.236.236.236.134.324.116.48.01.40.50.10.00.00.00.0
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.55$-0.86
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.55$-0.86
Shares Outstanding36.236.236.236.236.236.236.236.136.136.1
Diluted Shares Outstanding36.236.236.236.259.136.258.236.136.136.1
Current Assets TTM 2024202320222021202020192018201720162015201420132012
Cash And Equivalents26.49.313.514.910.39.66.08.25.15.79.46.620.40.9
Short Term Investments0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments26.49.313.514.910.39.66.08.25.15.79.46.620.40.9
Accounts Receivable1.20.73.41.93.00.60.00.00.00.60.10.10.00.6
Inventory0.00.00.00.0-3.0-0.60.00.00.0-0.60.00.00.00.0
Other Current Assets3.31.32.310.34.71.20.60.30.30.60.50.30.20.1
Total Current Assets30.911.319.227.015.010.86.78.45.46.410.07.020.51.7
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents14.84.311.79.317.126.437.913.524.012.5
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments14.84.311.79.317.126.437.913.524.012.5
Accounts Receivable0.82.20.20.72.21.21.73.48.58.6
Inventory0.00.00.00.00.00.0-1.70.00.00.0
Other Current Assets1.41.01.21.33.03.33.92.34.15.7
Total Current Assets16.97.513.211.322.430.941.719.236.626.8
Long-Term Assets TTM 2024202320222021202020192018201720162015201420132012
Net Property, Plant & Equipment57.154.957.346.738.112.84.20.50.81.11.11.20.10.1
Goodwill3.53.53.53.53.53.53.50.00.00.07.67.64.37.4
Intangible Assets10.310.310.310.310.310.310.33.04.910.812.812.812.912.9
Long-Term Investments5.55.50.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets-9.21.08.28.43.02.10.80.00.00.00.00.00.00.0
Total Long-Term Assets77.475.179.268.854.828.718.83.55.811.821.521.617.420.4
Total Assets108.386.498.495.869.839.525.511.911.118.231.528.637.922.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment52.553.254.054.955.957.156.957.354.152.5
Goodwill3.53.53.53.53.53.53.53.53.53.5
Intangible Assets0.010.310.310.310.310.310.310.310.310.3
Long-Term Investments0.00.05.45.50.05.55.55.75.85.7
Other Long-Term Assets16.66.41.01.06.21.02.52.58.38.2
Total Long-Term Assets72.673.374.175.175.877.478.690.876.274.4
Total Assets89.580.887.386.498.2108.3120.4110.0112.8101.2
Current Liabilities TTM 2024202320222021202020192018201720162015201420132012
Accounts Payable1.70.81.61.71.11.00.50.70.61.71.50.02.11.9
Short-Term Debt118.043.419.017.01.52.31.30.00.00.80.00.00.03.6
Other Current Liabilities3.54.1-4.16.22.23.53.01.81.40.20.71.60.00.5
Current Liabilities123.248.216.524.94.86.74.92.62.03.62.41.92.16.1
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.01.01.00.81.81.72.11.63.89.6
Short-Term Debt87.5116.8107.243.4112.4118.0104.219.013.440.9
Other Current Liabilities52.42.32.34.14.03.53.8-4.14.71.1
Current Liabilities140.0120.1110.548.2118.2123.2110.016.521.951.6
Long-Term Liabilities TTM 2024202320222021202020192018201720162015201420132012
Long-Term Debt28.283.1110.931.836.510.91.60.00.00.00.00.00.00.0
Capital Leases28.232.138.148.838.012.42.90.00.00.00.00.00.00.0
Def. Tax Liability3.13.13.13.13.13.13.10.81.12.43.03.10.03.1
Total Liabilities154.4134.5130.459.844.420.710.93.43.48.518.825.252.29.1
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt26.827.127.483.127.928.263.7110.9100.227.4
Capital Leases31.431.631.932.132.934.828.428.641.642.0
Def. Tax Liability3.13.13.13.13.13.13.114.73.13.1
Total Liabilities185.1150.3141.0134.5149.2154.4176.9142.0125.182.1
Total Common Equity TTM 2024202320222021202020192018201720162015201420132012
Common Stock0.40.40.40.40.30.20.10.30.10.20.12.01.80.7
Retained Earnings-324.9-327.7-308.8-239.8-202.9-179.7-157.5-406.3-394.2-381.4-362.5-362.0-387.2-320.5
Comprehensive Income0.00.00.00.00.00.00.00.0-11.1-18.2-1.5-12.3-0.10.0
Total Common Equity-46.1-48.0-32.136.125.418.914.68.57.79.712.73.4-14.212.9
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.40.40.40.40.40.40.40.40.40.4
Retained Earnings-377.2-350.6-334.3-327.7-330.3-324.9-333.8-308.8-289.0-257.8
Comprehensive Income0.00.00.00.00.00.00.00.00.00.0
Total Common Equity-95.6-69.5-53.8-48.0-51.0-46.1-56.5-32.1-12.419.1
Other TTM 2024202320222021202020192018201720162015201420132012
Total Debt146.1126.5120.448.838.013.22.90.00.00.80.00.00.03.6
Book Value-46.1-48.0-32.136.125.418.914.68.57.79.712.73.4-14.212.9
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value-95.6-69.5-53.8-48.0-51.0-46.1-56.5-32.1-12.419.1
Cash Flow From Operating Activities TTM 20252024202320222021202020192018201720162015201420132012
Net Income-67.0-173.8-18.9-69.0-36.9-23.2-22.2-19.5-12.1-12.8-18.8-0.523.1-58.4-4.3
Depreciation & Amortization1.11.51.31.00.91.21.11.40.40.40.40.30.20.10.1
Stock-Based Compensation1.72.62.90.93.12.93.54.30.50.72.00.51.91.40.0
Change Working Capital-1.7-1.4-2.1-9.60.4-3.2-0.9-2.20.3-0.50.7-0.2-0.61.1-0.2
Change In Accounts Receivable-0.70.00.00.00.00.00.00.00.00.40.10.0-0.10.00.1
Change In Accounts Payable-2.2-0.3-3.80.03.70.20.5-1.40.3-0.80.30.3-1.00.2-0.5
Change In Inventories0.70.00.00.00.00.00.00.00.00.00.10.00.00.60.0
Other Non-cash Items29.2145.3-20.829.40.00.10.60.91.84.35.8-9.8-37.25.20.0
Cash from Operations-38.60.00.0-47.4-32.5-23.6-18.3-15.6-9.4-9.2-10.6-9.8-12.6-7.4-4.3
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-124.3-26.7-16.3-6.52.6-5.59.0-25.0-19.8-31.2
Depreciation & Amortization0.40.40.40.40.40.30.30.30.30.2
Stock-Based Compensation0.60.60.60.80.40.71.30.00.2-0.4
Change Working Capital0.01.8-2.0-1.21.2-1.0-0.7-1.70.60.1
Change In Accounts Receivable0.00.00.00.00.00.00.00.0-0.70.0
Change In Accounts Payable-0.30.8-0.3-0.6-1.70.0-0.7-1.50.4-0.4
Change In Inventories0.00.00.00.00.00.00.00.00.70.0
Other Non-cash Items116.619.610.1-1.0-12.5-3.3-20.215.811.117.7
Cash from Operations0.00.00.00.00.00.00.00.0-8.1-9.7
Cash Flow From Investing Activities TTM 20252024202320222021202020192018201720162015201420132012
Capital Expenditure-7.5-0.5-1.9-8.1-2.2-1.3-0.8-0.10.0-0.1-0.3-0.2-1.2-0.1-0.1
Acquisitions0.00.00.00.00.00.00.03.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.00.00.00.00.00.03.2
Cash from Investing-7.50.00.0-8.1-2.2-1.3-0.82.90.0-0.1-0.3-0.2-1.2-0.13.1
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.1-0.2-0.1-0.10.1-0.3-1.4-0.3-2.4-3.5
Acquisitions0.00.00.00.00.00.00.00.00.00.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Investing0.00.00.00.00.00.00.00.0-2.4-3.5
Cash Flow From Financing Activities TTM 20252024202320222021202020192018201720162015201420132012
Debt Repaid-104.70.00.054.00.00.00.00.00.0-0.8-0.10.00.00.00.0
Debt Issued224.5126.56.1125.610.824.810.32.90.00.00.90.00.0-3.63.6
Issuance of Common Stock0.10.00.00.044.426.322.910.012.29.47.612.40.018.00.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0-0.20.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0-0.10.00.00.00.0
Other Financing Activities24.80.00.00.0-0.4-0.80.3-1.00.20.10.00.40.09.01.0
Cash from Financing59.80.00.054.044.025.523.29.012.58.77.212.80.027.01.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.024.8
Debt Issued114.4-29.69.38.1-13.8-5.8-21.847.56.7112.1
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.00.00.00.00.0-0.10.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Financing0.00.00.00.00.00.00.00.00.024.8
Cash position TTM 20252024202320222021202020192018201720162015201420132012
Net Change in Cash14.1-0.7-4.5-1.69.30.64.1-3.73.0-0.6-3.72.8-13.819.5-0.2
Closing Cash Balance26.414.114.819.220.811.510.86.78.25.15.79.46.620.40.9
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-6.110.4-7.42.3-7.9-9.3-11.524.3-10.411.6
Closing Cash Balance14.114.89.717.114.822.626.437.913.529.8
Free Cash Flow TTM 20252024202320222021202020192018201720162015201420132012
Free Cash Flow-46.1-26.3-39.4-55.6-34.7-24.9-19.1-15.7-9.4-9.3-10.9-10.0-13.8-7.6-4.3
Real Free Cash Flow-47.8-28.9-42.3-56.5-37.8-27.8-22.6-20.0-9.9-10.0-12.9-10.5-15.7-9.0-4.3
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-6.7-4.5-7.4-7.7-7.9-9.2-11.5-10.8-10.5-13.2
Real Free Cash Flow-7.4-5.2-7.9-8.5-8.2-9.9-12.9-10.8-10.7-12.8
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1.7-9.2-1.4
P/S62222.49.4
P/B-3.21.45.2
P/FCF-10.5-3-1.5
Market cap$0.2$0.1
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets127.7 %31.1 %0 %
Debt to Income-65.8 %-565.2 %0 %
Debt to Free cash flow-395.5 %-264.6 %0 %
Interest expense percentage-53.1 %-6.9 %44.7 %
Current ratio0.1 3.2 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE181.8 %-14.2 %0 %
ROA-194.2 %-49.2 %0 %
CapEx to Revenue8.2 %107 %0 %
RaD to Revenue0 %2868.5 %0 %
ROEM81,733.3 698284.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin70.5 %69.2 %68.7 %
Operating margin-659.9 %-6922.6 %35.5 %
Net margin-928 %-7029.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding36.2 mil 15.3 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader